Targeting the USP7-PRMT6 epigenetic axis overcomes chemoresistance in breast cancer by coordinating H3R2me2a deposition and RNF168 methylation for DNA repair and ferroptosis blockade.

Yang T; Wen H; Zhang J; Pan Y; Yang F; Wu X; Zhao J; Peng K; Yang L; Mei J

doi:10.1038/s41418-026-01672-2

Targeting the USP7-PRMT6 epigenetic axis overcomes chemoresistance in breast cancer by coordinating H3R2me2a deposition and RNF168 methylation for DNA repair and ferroptosis blockade.

Identifier:nobleid.org/w1/20260515/BAF5B667

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BAF5B667.svg?ark=w1%2F20260515%2FBAF5B667)](https://nobleid.org/work/w1/20260515/BAF5B667)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Targeting the USP7-PRMT6 epigenetic axis overcomes chemoresistance in breast cancer by coordinating H3R2me2a deposition and RNF168 methylation for DNA repair and ferroptosis blockade.

Identifier:nobleid.org/w1/20260515/BAF5B667

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BAF5B667.svg?ark=w1%2F20260515%2FBAF5B667)](https://nobleid.org/work/w1/20260515/BAF5B667)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work